Novigenix expands Advisory Board with influential scientific and commercial opinion leaders
Novigenix expands Advisory Board with influential scientific and commercial opinion leaders LAUSANNE, SWITZERLAND - October 26th, 2021 – Novigenix SA, a leading Swiss biotech that develops and commercializes Immuno-Transcriptomic precision oncology solutions is thrilled to announce the nomination of three leading figures to the Advisory Board. "We are pleased and honored to welcome Professor